Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026

Phase 1MAIA-OvarianPositive

AI Analysis

Summary

Compugen will present a Phase 1 trial-in-progress poster for MAIA-Ovarian at the ESMO Gynaecological Cancers Congress 2026, a routine conference presentation of early-stage clinical data in ovarian cancer.

Clinical Trial Data

Phase

Phase 1

Importance:5/10

Sentiment:

0.30

clinical_trialPhase_1oncologygynecological_cancerconference_presentation

Related Companies

$CGEN

Read the original article

Published by yahoo_finance on June 11, 2026 11:00 AM

Read Original